Heidi Kay, Ph.D.
Dr. Kay has been working in drug development since 1999, initially as a faculty member at the University of South Florida, where she was the lead inventor for a new class of anticancer drug candidates targeting STAT3, in collaboration with researchers at the H. Lee Moffitt Cancer Center. Her career in research laboratories began early, as an undergraduate student, working her way through school. Dr. Kay moved on to establish Jericho Sciences, LLC in 2009 to develop new independent research discoveries to help improve the lives of HIV-infected individuals. Dr. Kay earned a Doctorate Degree in Physical Chemistry in 1999 at the University of South Florida.